Main Menu
Category Menu
Contact Details
- +1-(978) 251-1206
- Gearperformance@mail.com
- 23 Lovett Ln North Chelmsford, Massachusetts(MA), 01863
End of Content.
End of Content.
In Stock
LGD-4033 was developed by Ligand Pharmaceuticals and is currently being investigated in clinical trials by Viking Therapeutics as a potential treatment for conditions involving muscle wasting and bone loss, such as those associated with hip fracture recovery, osteoporosis, and cancer cachexia.
LGD-4033 was developed by Ligand Pharmaceuticals and is currently being investigated in clinical trials by Viking Therapeutics as a potential treatment for conditions involving muscle wasting and bone loss, such as those associated with hip fracture recovery, osteoporosis, and cancer cachexia.
Reviews
There are no reviews yet.